Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS0159 in Chinese Healthy Subjects

Inclusion Criteria: 1. Healthy adult subjects of 18 years to 55 years. 2. Weight: Male≥50kg, female≥45kg BMI: 18\~32kg/m². 3. In good health, determined by having no clinically significant findings from medical history, physical examination, 12-lead ECG, vital signs measurements, and clinical laboratory evaluation. 4. Subject signs IFC and dates and subject must understand and follow test procedures and restrictions. Exclusion Criteria: 1. Subjects with special dietary requirements and cannot follow a uniform diet. 2. Pregnant or nursing females or females who have pregnancy plans during the trial or within 3 months after the trial. 3. Any subject with SARS-CoV-2 infection, based on a positive polymerase chain reaction for SARS-CoV-2. 4. History or evidence of clinically significant disorder, condition, or disease that, in the opinion of the investigator, would pose a risk to subject safety or interfere with the study evaluations, procedures, or completion.